Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver Function | BeOne Medicines

Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver Function

Beigene Study ID

BGB-3111-107

ClinicalTrials.gov ID

NCT03465059

Study Overview

Sex: All

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? yes

No Study Documents